Jiufuyuan Biotechnology Company Limited (JFY)
Jiufuyuan Biotechnology Company will go public soon, but the exact IPO date is still unknown.
IPO Price
$5.00
Shares Offered
Unknown
Deal Size
Unknown
JFY Statistics
Total Valuation
| Market Cap | n/a |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | 0.48 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 3.25 |
| Debt / FCF | 13.71 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 16.30% and return on invested capital (ROIC) is 38.62%.
| Return on Equity (ROE) | 16.30% |
| Return on Assets (ROA) | 9.99% |
| Return on Invested Capital (ROIC) | 38.62% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, JFY had revenue of $7.14 million and earned $668,437 in profits.
| Revenue | 7.14M |
| Gross Profit | 3.06M |
| Operating Income | 2.42M |
| Pretax Income | 668,437 |
| Net Income | 668,437 |
| EBITDA | 668,437 |
| EBIT | 668,437 |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has $742,230 in cash and $2.17 million in debt, giving a net cash position of -$1.43 million.
| Cash & Cash Equivalents | 742,230 |
| Total Debt | 2.17M |
| Net Cash | -1.43M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 4.10M |
| Book Value Per Share | n/a |
| Working Capital | 733,339 |
Cash Flow
In the last 12 months, operating cash flow was $617,690 and capital expenditures -$459,114, giving a free cash flow of $158,576.
| Operating Cash Flow | 617,690 |
| Capital Expenditures | -459,114 |
| Free Cash Flow | 158,576 |
| FCF Per Share | n/a |
Margins
Gross margin is 42.87%, with operating and profit margins of 33.93% and 9.36%.
| Gross Margin | 42.87% |
| Operating Margin | 33.93% |
| Pretax Margin | 9.36% |
| Profit Margin | 9.36% |
| EBITDA Margin | 9.36% |
| EBIT Margin | 9.36% |
| FCF Margin | 2.22% |
Dividends & Yields
JFY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |